Lipoic acid as a potential first agent for protection from mycotoxins and treatment of mycotoxicosis

Archives of Environmental Health

Volumn 58, Issue 8, 2003, Pages 528-532

  Rogers, Sherry A ^a,b  

^a Northeast Ctr for Environ Medicine   (United States)

^b Northeast Ctr for Environ Medicine   (United States)

Author keywords

Lipoic acid; Mycotoxicosis; Thioctic acid; Xenobiotic detoxification

Indexed keywords

MYCOTOXIN; THIOCTIC ACID; XENOBIOTIC AGENT;

DETOXIFICATION; DRUG COST; FUNGUS; HEALTH HAZARD; HUMAN; MOULD; MYCOTOXICOSIS; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

AIR POLLUTION, INDOOR; ANIMALS; ANTIOXIDANTS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HUMANS; INHALATION EXPOSURE; MYCOTOXICOSIS; MYCOTOXINS; SICK BUILDING SYNDROME; THIOCTIC ACID; XENOBIOTICS;

FUNGI;

EID: 3042692850     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.3200/AEOH.58.8.528-532     Document Type: Review

References (92)

1. Rogers SA. Indoor fungi as part of the cause of recalcitrant symptoms of the tight building syndrome. Environment Int 1991; 17(4):271-76.
2. Savilahti R, Uitti J, Roto P, et al. Increased prevalence of atopy among children exposed to mold in a school building. Allergy 2001; 56:175-79.
3. Dziadzio L, Bush RK. Assessment and control of fungal allergens. Curr Allergy Asthma Rep 2001; 1:455-60.
4. Rogers SA. A 13-month work, leisure, sleep environmental fungal survey. Ann Allergy 1984; 52:338-41.
5. Rogers SA. Diagnosing the tight building syndrome. Environ Health Perspect 1987; 76:195-98.
6. Santilli J Jr, Rockwell WJ, Collins RP. Individual patterns of immediate skin reactivity to mold extracts. Ann Allergy 1990; 65:454-58.
7. Hayes JR, Campbell TC. Food additives and contaminants. In: Klaasen CD, Amdur MO, Doull J (Eds). Casarett and Doull's Toxicology. The Basic Science of Poisons, 3rd ed. New York: Macmillan, 1986; pp 794-800.
8. Watson DH. Toxic fungal metabolites in food. Crit Rev Food Sci Nutr 1985; 22(3):177-98.
9. Fukushima C, Matsuse H, Tomari S, et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90:646-51.
10. Beasley VR. Trichothecene Mycotoxicosis: Pathophysiologic Effects, Vol 2. Boca Raton, FL: CRC Press, 1989.
11. Yarom R, Sherman Y, Yagen B, et al. T-2 toxin effect on bacterial infection and leukocyte functions. Toxicol Appl Pharmacol 1985; 75:60-65.
12. Wang JS, Groopman JD. DNA damage by mycotoxins. Mutat Res 1999; 424:167-81.
13. 1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 1993; 90:8586-90.
14. Newberne PM. Chemical carcinogenesis: mycotoxins and other chemicals to which humans are exposed. Semin Liver Dis 1984; 4(2):122-35.
15. Nyandieka HS, Wakhisi J, Kilonzo MM. Association of reduction of AFB1-induced liver tumors by antioxidants with increased activity of microsomal enzymes. Indian J Med Res 1990; 92:332-36.
16. 1-induced carcinomas by reduced glutathione. Science 1981; 212(4494):541-42.
17. 1. Nutr Cancer 1991; 15: 87-95.
18. Lei DN, Wang LQ, Ruebner BH, et al. Effect of selenium on aflatoxin hepatocarcinogenesis in the rat. Biomed Environ Sci 1990; 3(1):65-80.
19. Ueno Y. The toxicology of mycotoxins. Crit Rev Toxicol 1983; 14(2):99-132.
20. Uragashi K. Mycotoxic origin of cardiac beriberi. J Stored Prod Res 1969; 5:227.
21. Kroft WA, Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atmos Environ 1986; 20(3): 549-52.
22. Etzel RE, Montana E, Sorenson W, et al. Acute hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 1998; 152:757-62.
23. 1-induced mammary cancer in Wistar rats during treatment with BCG vaccine. Patol Pol 1986; 37(3):222-36.
24. Nassar AY, Galal AF, Mohamed MA, et al. The effect of aflatoxin B1 on the utilization of serum calcium. Mycopathologia 1985; 91(2):127-31.
25. Lindsay DG. Zeranol-a "nature-identical" oestrogen? Food Chem Toxicol 1985; 23(8):767-74.
26. Parish RC, Doering PL. Treatment of Amanita mushroom poisoning: a review. Vet Hum Toxicol 1986; 28(4): 318-22.
27. Wieland TH, Faulstich H. Amatoxin, phallotoxins, phallolysin and antaminide: the biologically active components of poisonous Amanita mushrooms, Crit Rev Biochem 1978; 5:185-260.
28. Culliton BJ. The destroying angel: a story of a search for an antidote. Science 1974; 185:600-01.
29. Berkson BM. Thioctic acid in treatment of hepatotoxic mushroom poisoning. N Engl J Med 1979; 300:371.
30. Berkson B. Treatment of four patients with thioctic acid. In: Faulstich H, Kommerell B, Wieland T (Eds). Amanita Toxins and Poisonings. Baden Baden, Germany: Verlag Gerhard Witzstrock, 1980; pp 203-07.
31. Teutsch C, Brennan RW. Amanita mushroom poisoning with recovery from coma, a case report. Ann Neurol 1978; 3:171-79.
32. Vesconi S, Langer M. Therapy of cytotoxic mushroom intoxication. Crit Care Med 1985; 13:402-06.
33. Roldan EJA, Lloret AP. Thioctic acid in Amanita poisoning. Crit Care Med 1986; 14:753.
34. Zulik R. Death cap poisoning. Lancet 1972; 11:288.
35. Becker CE. Diagnosis and treatment of Amanita phylloides-type mushroom poisoning: use of thioctic acid. West J Med 1976; 125:100-09.
36. Piering WF, Bratanow N. Role of the clinical laboratory in guiding treatment of Amanita virosa mushroom poisoning: report of two cases. Clin Chem 1990; 36(3):571-74.
37. Nagy I, Pogatsa-Murray G, Zalanyi S Jr, et al. Amanita poisoning during the second trimester of pregnancy. A case report and a review of the literature. Clin Investig 1994; 72:794-98.
38. Sabeel AI, Kurkus J, Lindholm T. Intensive hemodialysis and hemoperfusion treatment of Amanita mushroom poisoning. Mycopathologia 1995; 131:107-14.
39. Bartter FC, Berkson B, Gallelli J. Thioctic acid in the treatment of poisoning with alpha-amanitin. In: Faulstich H, Kommerell B, Wieland T (Eds). Amanita Toxins and Poisoning. Baden Baden, Germany: Verlag Gerhard Witzstrock, 1980; pp 197-202.
40. Steyn DG. The treatment of cases of Amanita phylloides and Amanita capensis poisoning. S Afr Med J 1966; 40: 405-06.
41. Berkson BM. A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. Med Klin 1994; 94:S84-89.
42. Suzuki Y, Tsuchiiya M, Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Rad Res Commun 1991; 15:255-63.
43. Scott B, Aruoma O. Lipoic and dihydrolipoic acid as antioxidants. Free Radic Res 1994; 20:119-33.
44. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-50.
45. Dikalov S, Khramtsov C, Zimmer G. Reaction of lipoate and its derivatives with reactive oxygen species. In: Fuchs J, Packer L, Zimmer G (Eds). Lipoic Acid in Health and Disease. New York: Marcel Dekker, 1997; pp 47-66.
46. Hagen TM, Ingersoll RT, Lykkesfeldt J, et al. (R)- α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 1999; 13:411-18.
47. Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 1995; 50:123-26.
48. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29:315-31.
49. Muller L, Menzel H. Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium toxicity in isolated hepatocytes. Biochem Biophys Acta 1990; 1052:386-91.
50. Bauer A, Harrer T, Peukert M, et al. Alpha-lipoic acid is an effective inhibitor of human immunodeficiency virus replication. Wien Klin Wochenschr 1991; 69:722-24.
51. Grieb G. Alpha lipoic acid inhibits HIV replication. Med Monatsschr Pharma 1992; 15(8):243-44.
52. Zimmer G, Manika L, Kruger E. Dihydrolipoic acid activates oligomycin-sensitive thiol groups and increases ATP synthesis in mitochondria. Arch Biochem Biophys 1991; 288:609-13.
53. Packer L. Antioxidant properties of lipoic acid and its therapeutic effect in prevention of diabetes complications and cataracts. Ann NY Acad Sci 1994; 734:257-64.
54. O'Neill CA, Hallowell B. Aldehyde-induced protein modifications in human plasma. Protection by glutathione and dihydrolipoic acid. J Lab Clin Med 1994; 124(3):359-70.
55. Thompson CM. Addition of thioctic acid to a plan for management of hepatic insufficiency. Am J Med 1956; 21:131-32.
56. Kemplay S, Martin P, Wilson S. The effects of thioctic acid on motor nerve terminals in acrylamide-poisoned rats. Neuropathol Appl Neurobiol 1988; 14:275-88.
57. Altenkirch H, Stoltenberg-Didinger H, Wagner H, et al. Effect of lipoic acid in carbon-induced neuropathy. Neurotoxicol Teratol 1990; 12:619-22.
58. Sandhya P, Varalakshmi P. Effect of lipoic acid administration lipid peroxidation in rats. J Appl Toxicol 1997; 17: 405-08.
59. Conlon BJ, Aran JM, Erre JP, et al. Attenuation of amino glycosides-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear Res 1999; 128(1-2): 40-44.
60. Gut J, Christen U, Frey N, et al. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens. Toxicology 1995; 97 (1-3):199-224.
61. Arivazhagen P, Juliet P, Panneerselvam C. Effect of DL-alpha lipoic acid on the status of lipid peroxidation and antioxidants in aged rats. Pharmacol Res 2000; 41: 299-303.
62. Halliwell B, Gutteriedge JMC. Free Radicals in Biology and Medicine, 3rd ed. New York: Oxford University Press, 1999; p 194.
63. Peinado J, Sies H, Akerboom TP. Hepatic lipoate uptake. Arch Biochem Biophys 1989; 273:389-95.
64. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22:359-78.
65. Nagamatsu M, Nickander KK, Low P, et al. α-lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995, 18(8):1160-67.
66. Nohl H, Gille L. Evaluation of the antioxidant capacity of ubiquinol and dihydrolipoic acid. J Biosci 1998; 53: 250-53.
67. Loffelhardt S, Bonaventura C, Locher M, et al. Interaction of α-lipoic acid in enantiomers and homologues with the enzyme components of the mammalian pyruvate dehydrogenase complex. Biochem Pharmacol 1995; 15(5):637-46.
68. Han D, Handleman G, Marcxocci L, et al. Lipoic acid increases the de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997; 6:321-38.
69. Wells WW, Xu DP, Yang Y, et al. Mammalian thiol transferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J Biol Chem 1990; 265:15361-64.
70. Hansen DE, Black G, Levine M. Ascorbic acid: biological functions and relation to cancer. J Natl Cancer Inst 1991; 83:547-50.
71. Podda M, Tritschler HJ, Ulrich H, et al. Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem Biophys Res Commun 1994; 204: 98-104.
72. Han D, Tritscherl HJ, Packer L. Alpha-lipoic acid increases intracellular glutathione in human T-lymphocyte Jurkat cell line. Biochem Biophys Res Commun 1995; 207: 258-64.
73. Ramkrishnan N, Wolff WW. Radioprotection of haemotopoietic tissues in mice by lipoic acid. Radiat Res 1992; 130:360-65.
74. Kropachova K, Mishurova E. Flavobion and thiocic acid lessen radiation-induced latent injury of the liver. Biull Eksp Biol Med 1992; 113(5):547-49.
75. Korkina LG, Afanasef IB, Diplock AT. Antioxidant therapy in children affected by a radiation from the Chernobyl nuclear accident. Biochem Soc Trans 1993; 21:S314.
76. Bast A, Haenen GRMM. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 1988; 963: 558-61.
77. Devasagayam TPA, Subramanian M, Pradhan DS, et al. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem Biol Interact 1993; 86:79-92.
78. Mizuno M, Packer L. Effects of alpha lipoic acid and dihydrolipoic acid on expression of proto-oncogene c-fos. Biochem Biophys Res Commun 1994; 200(2):1136-42.
79. Sumathi R, Devi VK, Varalakshmi P. DL α-lipoic acid protection against cadmium-induced tissue lipid peroxidation. Med Sci Res 1994; 22:23-25.
80. Kagan VE, Shvedova A, Servinova E, et al. Dihydrolipoic acid: a universal antioxidant both in the membrane and in the aqueous phase. Biochem Pharmacol 1992; 44: 1637-49.
81. Scholich H, Murphy ME, Eies H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on α-tocopherol. Biochim Biophys Acta 1989; 1001:256-61.
82. Berkson BM. Alpha-lipoic acid (thioctic acid): my experience with this outstanding therapeutic agent. J Orthomol Med 1998; 13(1):44-48.
83. Rogers SA. Detoxify or Die. Syracuse, NY: Prestige, 2002. Available from 〈www.prestigepublishing.com〉
84. Gal EM. Reversal of selective toxicity of (-)-α-lipoic acid by thiamine in thiamine-deficient rats. Nature 1965; 207:535.
85. Gregus Z, Fekete T, Klaassen CD, et al. Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoylglycine. Drug Metab Dispos 1996; 245: 682-88.
86. Trickler D, Shklar G, Schwartz J. Inhibition of oral carcinogenesis by glutathione. Nutr Cancer 1993; 20(2):139-44.
87. Vogel G, Tuchweber B, Trost W, et al. Protection by silibinin against Amanita phylloides intoxication in beagles. Toxicol Appl Pharmacol 1984; 73:355-62.
88. 1-induced rat plasma α-foetoprotein elevation, hepatic tumorigenesis, and mutagenicity of urine. Food Chem Toxicol 1982; 20:47-52.
89. 1 activation. Biochem Pharmacol 1990; 39(1):19-26.
90. Kojima R, Toyama Y, Ohnishi ST. Protective effects of an aged garlic extract on doxorubicin-induced cardiotoxicity in the mouse. Nutr Cancer 1994; 22:163-73.
91. Geetha A, Sankar R, Marar T, et al. Alpha tocopherol reduces doxorubicin-induced toxicity in rats: histological and biochemical evidences. Indian J Physiol Pharmacol 1990; 34:94-100.
92. 1 in rats. J Nutr 1982; 112(2):324-31.